Histone deacetylase inhibitor LBH589 radiosensitizes non-small cell lung cancer by inhibiting DNA repair

被引:0
|
作者
Cuneo, K. C. [1 ]
Fu, A. [1 ]
Hallahan, D. E. [1 ]
Geng, L. [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA
关键词
D O I
10.1016/j.ijrobp.2006.07.314
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1049
引用
收藏
页码:S158 / S158
页数:1
相关论文
共 50 条
  • [1] A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Pretreated Patients with Small-Cell Lung Cancer
    de Marinis, Filippo
    Atmaca, Akin
    Tiseo, Marcello
    Giuffreda, Libero
    Rossi, Antonio
    Gebbia, Vittorio
    D'Antonio, Chiara
    Dal Zotto, Laura
    Al-Batran, Salah-Eddin
    Marsoni, Silvia
    Wolf, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (08) : 1091 - 1094
  • [2] Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer
    Leslie A. Garrett
    Whitfield B. Growdon
    Bo R. Rueda
    Rosemary Foster
    Journal of Ovarian Research, 9
  • [3] Influence of the novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer
    Garrett, L.
    Zhang, L.
    Guo, L.
    Therrien, V.
    Growdon, W.
    Foster, R.
    Rueda, B.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S71 - S71
  • [4] Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer
    Garrett, Leslie A.
    Growdon, Whitfield B.
    Rueda, Bo R.
    Foster, Rosemary
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [5] The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotype
    Fortunati, Nicoletta
    Marano, Francesca
    Bandino, Andrea
    Frairia, Roberto
    Catalano, Maria Graziella
    Boccuzzi, Giuseppe
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (03) : 700 - 708
  • [6] Histone deacetylase (HDAC) inhibitor LBH589 increases duration of γ-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer
    Geng, Ling
    Cuneo, Kyle C.
    Fu, Allie
    Tu, Tianxiang
    Atadja, Peter W.
    Hallahan, Dennis E.
    CANCER RESEARCH, 2006, 66 (23) : 11298 - 11304
  • [7] Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo
    Catalano, Maria Graziella
    Pugliese, Mariateresa
    Gargantini, Eleonora
    Grange, Cristina
    Bussolati, Benedetta
    Asioli, Sofia
    Bosco, Ornella
    Poli, Roberta
    Compagnone, Alessandra
    Bandino, Andrea
    Mainini, Franco
    Fortunati, Nicoletta
    Boccuzzi, Giuseppe
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (03) : 694 - 704
  • [8] Combination Therapy with the Histone Deacetylase Inhibitor LBH589 and Radiation Is an Effective Regimen for Prostate Cancer Cells
    Xiao, Weiwei
    Graham, Peter H.
    Hao, Jingli
    Chang, Lei
    Ni, Jie
    Power, Carl A.
    Dong, Qihan
    Kearsley, John H.
    Li, Yong
    PLOS ONE, 2013, 8 (08):
  • [9] The Histone Deacetylase Inhibitor LBH589 (Panobinostat) Modulates the Crosstalk of Lymphocytes with Hodgkin Lymphoma Cell Lines
    Klein, Jan M.
    Henke, Alexander
    Sauer, Maike
    Bessler, Martina
    Reiners, Katrin S.
    Engert, Andreas
    Hansen, Hinrich P.
    von Strandmann, Elke Pogge
    PLOS ONE, 2013, 8 (11):
  • [10] Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor dependent human lung cancer cells
    Haura, E.
    Edwards, A.
    Bhalla, K.
    EJC SUPPLEMENTS, 2006, 4 (12): : 182 - 183